2m 2m 2m 2m 2m 2m 2m
Lite Strategy (LITS)
NASDAQ
$1.17-$0.02 (-2.02%)
Price as of Oct 22, 2026 6:01 PM EDT- $37.7MMarket Cap
- -33.33%1-Year Change
- BiotechnologyIndustry
Lite Strategy (LITS)
$1.17-$0.02 (-2.02%)
LITS | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.19 | ||
Change | +$0.05 (+4.20%) | ||
Open | $1.23 | ||
High | $1.23 | ||
Low | $1.18 | ||
Previous Close | $1.24 | ||
Volume | 168,960 | ||
30-Day Average Volume | 848,238 | ||
1-Week Change | 5.98% | ||
1-Month Change | -3.12% | ||
1-Year Change | -33.33% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 30.4M | ||
Total Assets | $42.7M | ||
Market Cap | $37.7M | ||
Enterprise Value | $32.0M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$13.0M | ||
Free Cash Flow | -$1.2M | ||
EBIT | -$13.0M | ||
EBITDA | -$13.0M | ||
Net Working Capital | $5.1M | ||
EPS | -$0.36 | ||
Enterprise Value/EBITDA | -2 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -32 | ||
Price/Operating Cash Flow | -32 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue